COYA
Price
$6.40
Change
-$0.16 (-2.44%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
109.21M
13 days until earnings call
NTLA
Price
$8.19
Change
+$0.10 (+1.24%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
846.77M
6 days until earnings call
Ad is loading...

COYA vs NTLA

Header iconCOYA vs NTLA Comparison
Open Charts COYA vs NTLABanner chart's image
Coya Therapeutics
Price$6.40
Change-$0.16 (-2.44%)
Volume$716
Capitalization109.21M
Intellia Therapeutics
Price$8.19
Change+$0.10 (+1.24%)
Volume$37.15K
Capitalization846.77M
COYA vs NTLA Comparison Chart
Loading...
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COYA vs. NTLA commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COYA is a Buy and NTLA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (COYA: $6.56 vs. NTLA: $8.09)
Brand notoriety: COYA and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COYA: 143% vs. NTLA: 69%
Market capitalization -- COYA: $111.05M vs. NTLA: $846.77M
COYA [@Biotechnology] is valued at $111.05M. NTLA’s [@Biotechnology] market capitalization is $846.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COYA’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • COYA’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, COYA is a better buy in the long-term than NTLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COYA’s TA Score shows that 5 TA indicator(s) are bullish while NTLA’s TA Score has 4 bullish TA indicator(s).

  • COYA’s TA Score: 5 bullish, 5 bearish.
  • NTLA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both COYA and NTLA are a good buy in the short-term.

Price Growth

COYA (@Biotechnology) experienced а +25.67% price change this week, while NTLA (@Biotechnology) price change was +17.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

COYA is expected to report earnings on May 08, 2025.

NTLA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($847M) has a higher market cap than COYA($109M). COYA YTD gains are higher at: 14.485 vs. NTLA (-29.846). COYA has higher annual earnings (EBITDA): -11.33M vs. NTLA (-523.98M). NTLA has more cash in the bank: 602M vs. COYA (31.1M). NTLA has higher revenues than COYA: NTLA (57.9M) vs COYA (9.55M).
COYANTLACOYA / NTLA
Capitalization109M847M13%
EBITDA-11.33M-523.98M2%
Gain YTD14.485-29.846-49%
P/E RatioN/AN/A-
Revenue9.55M57.9M17%
Total Cash31.1M602M5%
Total DebtN/A210M-
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COYANTLA
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 17 days ago
87%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CSCCF4.750.34
+7.78%
CAPSTONE COPPER CORP.
LSRCY17.450.42
+2.47%
Lasertec Corp.
BIOF0.13N/A
-0.70%
Blue Biofuels Inc.
ARZGY17.66-0.28
-1.56%
Assicurazioni Generali Spa
NSRGF104.32-1.93
-1.82%
Nestle S.A.

COYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, COYA has been loosely correlated with KNSA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if COYA jumps, then KNSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COYA
1D Price
Change %
COYA100%
-1.20%
KNSA - COYA
37%
Loosely correlated
+4.20%
NTLA - COYA
32%
Poorly correlated
-2.65%
GANX - COYA
32%
Poorly correlated
+0.22%
SNDX - COYA
31%
Poorly correlated
+0.62%
ATXS - COYA
30%
Poorly correlated
+12.55%
More

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with VCYT. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
+1.11%
VCYT - NTLA
69%
Closely correlated
+2.15%
CRSP - NTLA
66%
Loosely correlated
+1.48%
BEAM - NTLA
64%
Loosely correlated
+1.51%
RXRX - NTLA
60%
Loosely correlated
+3.05%
RCKT - NTLA
59%
Loosely correlated
+4.06%
More